Cytokine functions in the formative stages of a lymphocyte's life

Current Opinion in Immunology

Volumn 16, Issue 2, 2004, Pages 180-190

  Kang, Joonsoo ^a   Der, Sandy D ^b  

^a UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF TORONTO   (Canada)

Author keywords

CIS; CLP; Common lymphoid progenitor; Cytokine induced suppressor; Fetal liver kinase 2 ligand; Flk 2L; Gfi; GM CSF; Granulocyte macrophage colony stimulating factor; Growth factor independence; Helix loop helix; Hematopoietic stem cell; HLH; HSC; IL; Interleukin

Indexed keywords

CD8 ANTIGEN; CYTOKINE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 15; INTERLEUKIN 2; INTERLEUKIN 21; INTERLEUKIN 4; INTERLEUKIN 7; INTERLEUKIN 9; JANUS KINASE; JANUS KINASE 2; LIGAND; LYMPHOCYTE ANTIGEN RECEPTOR; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE 1; PHOSPHOTYROSINE; PROTEIN; PROTEIN DERIVATIVE; PROTEIN SH2; STAT5 PROTEIN; STEM CELL FACTOR; SUPPRESSOR OF CYTOKINE SIGNALING 1; THYMIC STROMALLYMPHOPOIETIN; TRANSCRIPTION FACTOR NFAT; UNCLASSIFIED DRUG;

B LYMPHOCYTE; CALIBRATION; CELL ACTIVITY; CELL CYCLE; CELL DIFFERENTIATION; CELL LINEAGE; CELL MATURATION; CELL SURVIVAL; CHROMATIN; COMPLEX FORMATION; CORRELATION ANALYSIS; CYTOKINE PRODUCTION; DEVELOPMENTAL STAGE; GENE LOCUS; GENETIC TRANSCRIPTION; HEMATOPOIESIS; LYMPHOCYTE; LYMPHOCYTE PROLIFERATION; LYMPHOPOIESIS; MITOCHONDRIAL RESPIRATION; MOLECULAR MECHANICS; NONHUMAN; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; QUANTITATIVE ANALYSIS; REVIEW; SIGNAL TRANSDUCTION; STROMA CELL; T LYMPHOCYTE; THYMUS;

ANIMALS; B-LYMPHOCYTES; CELL DIFFERENTIATION; CELL SURVIVAL; CYTOKINES; FMS-LIKE TYROSINE KINASE 3; GENE EXPRESSION REGULATION; LYMPHOPOIESIS; MICE; MODELS, BIOLOGICAL; PROTO-ONCOGENE PROTEINS; RECEPTOR PROTEIN-TYROSINE KINASES; RECEPTORS, INTERLEUKIN-7; SIGNAL TRANSDUCTION; STEM CELL FACTOR;

EID: 1542381087     PISSN: 09527915     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.coi.2004.02.002     Document Type: Review

References (82)

1. Park L.S., Martin U., Garka K., Gliniak B., Di Santo J.P., Muller W., Largaespada D.A., Copeland N.G., Jenkins N.A., Farr A.G.et al. Cloning of the murine thymic stromal lymphopoietin (TSLP) receptor: formation of a functional heteromeric complex requires interleukin 7 receptor. J. Exp. Med. 192:2000;659-670.
2. Isaksen D.E., Baumann H., Zhou B., Nivollet S., Farr A.G., Levin S.D., Ziegler S.F. Uncoupling of proliferation and Stat5 activation in thymic stromal lymphopoietin-mediated signal transduction. J. Immunol. 168:2002;3288-3294.
3. Peschon J.J., Morrissey P.J., Grabstein K.H., Ramsdell F.J., Maraskovsky E., Gliniak B.C., Park L.S., Ziegler S.F., Williams D.E., Ware C.B.et al. Early lymphocyte expansion is severely impaired in interleukin 7 receptor-deficient mice. J. Exp. Med. 180:1994;1955-1960.
4. Rodewald H.R., Waskow C., Haller C. Essential requirement for c-kit and common gamma chain in thymocyte development cannot be overruled by enforced expression of Bcl-2. J. Exp. Med. 193:2001;1431-1437.
5. -/- mice essentially lack all downstream progenies of the common lymphoid progenitor (CLP). The work also demonstrates that CLPs are responsive to IL-7 in vitro in the absence of stroma, and that these IL-7-stimulated cells are not capable of generating thymocytes in vivo.
6. -/- mice.
7. Carvalho T.L., Mota-Santos T., Cumano A., Demengeot J., Vieira P. Arrested B lymphopoiesis and persistence of activated B cells in adult interleukin 7(-/)- mice. J. Exp. Med. 194:2001;1141-1150.
8. Moriggl R., Topham D.J., Teglund S., Sexl V., McKay C., Wang D., Hoffmeyer A., van Deursen J., Sangster M.Y., Bunting K.D.et al. Stat5 is required for IL-2-induced cell cycle progression of peripheral T cells. Immunity. 10:1999;249-259.
9. Laky K., Lewis J.M., Tigelaar R.E., Puddington L. Distinct requirements for IL-7 in development of TCR gamma delta cells during fetal and adult life. J. Immunol. 170:2003;4087-4094.
10. neg/lo, suggesting that the earliest step in T-cell development may not require IL-7.
11. Sudo T., Nishikawa S., Ohno N., Akiyama N., Tamakoshi M., Yoshida H. Expression and function of the interleukin 7 receptor in murine lymphocytes. Proc. Natl. Acad. Sci. USA. 90:1993;9125-9129.
12. Yoshida H., Honda K., Shinkura R., Adachi S., Nishikawa S., Maki K., Ikuta K., Nishikawa S.I. IL-7 receptor alpha+ CD3(-) cells in the embryonic intestine induces the organizing center of Peyer's patches. Int. Immunol. 11:1999;643-655.
13. •], this paper shows that a transient downmodulation of IL-7R expression may be a necessary step in T and B lymphopoiesis.
14. Fleming H.E., Paige C.J. Pre-B cell receptor signaling mediates selective response to IL-7 at the pro-B to pre-B cell transition via an ERK/MAP kinase-dependent pathway. Immunity. 15:2001;521-531.
15. Kang J., Volkmann A., Raulet D.H. Evidence that gammadelta versus alphabeta T cell fate determination is initiated independently of T cell receptor signaling. J. Exp. Med. 193:2001;689-698.
16. Rincon M. MAP-kinase signaling pathways in T cells. Curr. Opin. Immunol. 13:2001;339-345.
17. ••].
18. ••] show that high expression of PU.1 is non-permissive for T- and B-cell development from fetal progenitors in fetal thymic organ cultures (FTOCs), but can instead be conducive for macrophage development. In normal hematopoietic cell development PU.1 may be required to maintain the myeloid differentiation program and inhibit lymphoid-lineage-specific gene expression.
19. Marsden V.S., Strasser A. Control of apoptosis in the immune system: Bcl-2, BH3-only proteins and more. Annu. Rev. Immunol. 21:2003;71-105.
20. Yu Q., Erman B., Bhandoola A., Sharrow S.O., Singer A. In vitro evidence that cytokine receptor signals are required for differentiation of double positive thymocytes into functionally mature CD8+ T cells. J. Exp. Med. 197:2003;475-487.
21. Akashi K., Kondo M., von Freeden-Jeffry U., Murray R., Weissman I.L. Bcl-2 rescues T lymphopoiesis in interleukin-7 receptor-deficient mice. Cell. 89:1997;1033-1041.
22. Wu T.S., Lee J.M., Lai Y.G., Hsu J.C., Tsai C.Y., Lee Y.H., Liao N.S. Reduced expression of Bcl-2 in CD8+ T cells deficient in the IL-15 receptor alpha-chain. J. Immunol. 168:2002;705-712.
23. Kovanen P.E., Rosenwald A., Fu J., Hurt E.M., Lam L.T., Giltnane J.M., Wright G., Staudt L.M., Leonard W.J. Analysis of gamma c-family cytokine target genes. Identification of dual-specificity phosphatase 5 (DUSP5) as a regulator of mitogen-activated protein kinase activity in interleukin-2 signaling. J. Biol. Chem. 278:2003;5205-5213.
24. -/- mice. Cell. 89:1997;1011-1019.
25. Kee B.L., Bain G., Murre C. IL-7Ralpha and E47: independent pathways required for development of multipotent lymphoid progenitors. EMBO J. 21:2002;103-113.
26. Jacobs H., Krimpenfort P., Haks M., Allen J., Blom B., Demolliere C., Kruisbeek A., Spits H., Berns A. PIM1 reconstitutes thymus cellularity in interleukin 7- and common gamma chain-mutant mice and permits thymocyte maturation in Rag- but not CD3gamma-deficient mice. J. Exp. Med. 190:1999;1059-1068.
27. Matsuzaki Y., Nakayama K., Tomita T., Isoda M., Loh D.Y., Nakauchi H. Role of bcl-2 in the development of lymphoid cells from the hematopoietic stem cell. Blood. 89:1997;853-862.
28. Wen R., Wang D., McKay C., Bunting K.D., Marine J.C., Vanin E.F., Zambetti G.P., Korsmeyer S.J., Ihle J.N., Cleveland J.L. Jak3 selectively regulates Bax and Bcl-2 expression to promote T-cell development. Mol. Cell. Biol. 21:2001;678-689.
29. •] also shows that, in addition to Bcl-2 induction, IL-7 inhibits pro-apoptotic protein Bad activity via the PI3K pathway in pro-T cells.
30. Trigueros C., Hozumi K., Silva-Santos B., Bruno L., Hayday A.C., Owen M.J., Pennington D.J. Pre-TCR signaling regulates IL-7 receptor alpha expression promoting thymocyte survival at the transition from the double-negative to double-positive stage. Eur. J. Immunol. 33:2003;1968-1977.
31. Smart F.M., Venkitaraman A.R. Inhibition of interleukin 7 receptor signaling by antigen receptor assembly. J. Exp. Med. 191:2000;737-742.
32. Fleming H.E., Paige C.J. Cooperation between IL-7 and the pre-B cell receptor: a key to B cell selection. Semin Immunol. 14:2002;423-430.
33. Kelly J.A., Spolski R., Kovanen P.E., Suzuki T., Bollenbacher J., Pise-Masison C.A., Radonovich M.F., Lee S., Jenkins N.A., Copeland N.G.et al. Stat5 synergizes with T cell receptor/antigen stimulation in the development of lymphoblastic lymphoma. J. Exp. Med. 198:2003;79-89.
34. Chowdhury D., Sen R. Stepwise activation of the immunoglobulin mu heavy chain gene locus. EMBO J. 20:2001;6394-6403.
35. ••] is an impressively executed study on the rhythmic and transient nature of IL-7 signaling, which is essential for the maintenance of accessible state of chromatin necessary for gene rearrangement. Diminished IL-7 signaling at pre-B cells results in hypoacetylated VH genes and termination of further gene rearrangement, perhaps contributing to the establishment of allelic exclusion.
36. Durum S.K., Candèias S., Nakajima H., Leonard W.J., Baird A.M., Berg L.J., Muegge K. Interleukin 7 receptor control of T cell receptor gamma gene rearrangement: role of receptor-associated chains and locus accessibility. J. Exp. Med. 188:1998;2233-2241.
37. Ye S., Maki K., Kitamura T., Sunaga S., Akashi K., Domen J., Weissman I.L., Honjo T., Ikuta K. Induction of germline transcription in the TCRg locus by Stat5: implications for accessibility control by the IL-7 receptor. Immunity. 11:1999;213-223.
38. Ye S.K., Agata Y., Lee H.C., Kurooka H., Kitamura T., Shimizu A., Honjo T., Ikuta K. The IL-7 receptor controls the accessibility of the TCRgamma locus by Stat5 and histone acetylation. Immunity. 15:2001;813-823.
39. Xiong N., Kang C., Raulet D.H. Redundant and unique roles of two enhancer elements in the TCRgamma locus in gene regulation and gammadelta T cell development. Immunity. 16:2002;453-463.
40. Hesslein D.G., Pflugh D.L., Chowdhury D., Bothwell A.L., Sen R., Schatz D.G. Pax5 is required for recombination of transcribed, acetylated, 5′ IgH V gene segments. Genes Dev. 17:2003;37-42.
41. Hirokawa S., Sato H., Kato I., Kudo A. EBF-regulating Pax5 transcription is enhanced by STAT5 in the early stage of B cells. Eur. J. Immunol. 33:2003;1824-1829.
42. Bain G., Romanow W.J., Albers K., Havran W.L., Murre C. Positive and negative regulation of V(D)J recombination by the E2A proteins. J. Exp. Med. 89:1999;289-300.
43. Ghosh J.K., Romanow W.J., Murre C. Induction of a diverse T cell receptor gamma/delta repertoire by the helix-loop-helix proteins E2A and HEB in nonlymphoid cells. J. Exp. Med. 193:2001;769-776.
44. Rich B.E., Campos-Torres J., Tepper R.I., Moreadith R.W., Leder P. Cutaneous lymphoproliferation and lymphomas in interleukin 7 transgenic mice. J. Exp. Med. 177:1993;305-316.
45. Kim K., Lee C.K., Sayers T.J., Muegge K., Durum S.K. The trophic action of IL-7 on pro-T cells: inhibition of apoptosis of pro-T1, -T2, and -T3 cells correlates with Bcl-2 and Bax levels and is independent of Fas and p53 pathways. J. Immunol. 160:1998;5735-5741.
46. Suzuki H., Terauchi Y., Fujiwara M., Aizawa S., Yazaki Y., Kadowaki T., Koyasu S. Xid-like immunodeficiency in mice with disruption of the p85alpha subunit of phosphoinositide 3-kinase. Science. 283:1999;390-392.
47. Fruman D.A., Snapper S.B., Yballe C.M., Davidson L., Yu J.Y., Alt F.W., Cantley L.C. Impaired B cell development and proliferation in absence of phosphoinositide 3-kinase p85alpha. Science. 283:1999;393-397.
48. -/- mice to date. The catalytic p110δ subunit is preferentially expressed in hematopoietic cells. Although the knockout mice show profound defects in mature B-cell activation, precursor B-cell subsets are present in normal numbers. Interestingly, B1 B cells and marginal zone B cells are lacking in the mutant mice, indicating selective functions of PI3K in distinct B-cell subpopulations.
49. Suzuki H., Matsuda S., Terauchi Y., Fujiwara M., Ohteki T., Asano T., Behrens T.W., Kouro T., Takatsu K., Kadowaki T.et al. PI3K and Btk differentially regulate B cell antigen receptor-mediated signal transduction. Nat. Immunol. 4:2003;280-286.
50. Sexl V., Piekorz R., Moriggl R., Rohrer J., Brown M.P., Bunting K.D., Rothammer K., Roussel M.F., Ihle J.N. Stat5a/b contribute to interleukin 7-induced B-cell precursor expansion, but abl- and bcr/abl-induced transformation are independent of stat5. Blood. 96:2000;2277-2283.
51. Guinamard R., Okigaki M., Schlessinger J., Ravetch J.V. Absence of marginal zone B cells in Pyk-2-deficient mice defines their role in the humoral response. Nat. Immunol. 1:2000;31-36.
52. Benbernou N., Muegge K., Durum S.K. Interleukin(IL)-7 induces rapid activation of Pyk2, which is bound to Janus kinase 1 and IL-7Ralpha. J. Biol. Chem. 275:2000;7060-7065.
53. Koziak K., Kaczmarek E., Park S.Y., Fu Y., Avraham S., Avraham H. RAFTK/Pyk2 involvement in platelet activation is mediated by phosphoinositide 3-kinase. Br. J. Haematol. 114:2001;134-140.
54. Staal F.J., Clevers H.C. Wnt signaling in the thymus. Curr. Opin. Immunol. 15:2003;204-208.
55. Reya T., Duncan A.W., Ailles L., Domen J., Scherer D.C., Willert K., Hintz L., Nusse R., Weissman I.L. A role for Wnt signalling in self-renewal of haematopoietic stem cells. Nature. 423:2003;409-414 This paper marks the definitive arrival of the canonical WNT signaling in HSC proliferation. Activation of WNT signaling in HSCs in vitro leads to upregulation of HoxB4 and Notch1 and increased cell cycle progression. Inhibition of WNT signaling results in diminution in proliferation and in vivo reconstitution capability of HSCs.
56. Chi T.H., Wan M., Lee P.P., Akashi K., Metzger D., Chambon P., Wilson C.B., Crabtree G.R. Sequential roles of Brg, the ATPase subunit of BAF chromatin remodeling complexes, in thymocyte development. Immunity. 19:2003;169-182 This work is an impeccable examination of T-cell development in mice lacking Brg, an integral component of the mammalian BAF complex. Brg-deficient cells do not differentiate, are susceptible to die (perhaps owing to the loss of Bcl-2 expression) and are cell cycle arrested. Pro-T cells lacking Brg show a selective loss of c-Kit expression as well as expression of other WNT target genes, suggesting that the WNT signaling is defective in Brg-deficient cells.
57. Staal F.J., Meeldijk J., Moerer P., Jay P., van de Weerdt B.C., Vainio S., Nolan G.P., Clevers H. Wnt signaling is required for thymocyte development and activates Tcf- 1 mediated transcription. Eur. J. Immunol. 31:2001;285-293.
58. -/- mice exhibit a progressive block in the generation of earliest lymphoid lineage progenitors, resulting in the loss of T and B lymphopoiesis. Hence, c-Kit signaling is essential for continued generation and/or maintenance of lymphoid progenitors.
59. Doan L.L., Kitay M.K., Yu Q., Singer A., Herblot S., Hoang T., Bear S.E., Morse H.C. III, Tsichlis P.N., Grimes H.L. Growth factor independence-1B expression leads to defects in T cell activation, IL-7 receptor alpha expression, and T cell lineage commitment. J. Immunol. 170:2003;2356-2366.
60. Yucel R., Karsunky H., Klein-Hitpass L., Moroy T. The transcriptional repressor Gfi1 affects development of early, uncommitted c-Kit+ T cell progenitors and CD4/CD8 lineage decision in the thymus. J. Exp. Med. 197:2003;831-844.
61. Sitnicka E., Bryder D., Theilgaard-Monch K., Buza-Vidas N., Adolfsson J., Jacobsen S.E. Key role of flt3 ligand in regulation of the common lymphoid progenitor but not in maintenance of the hematopoietic stem cell pool. Immunity. 17:2002;463-472.
62. Pido-Lopez J., Imami N., Andrew D., Aspinall R. Molecular quantitation of thymic output in mice and the effect of IL-7. Eur. J. Immunol. 32:2002;2827-2836.
63. Iwasaki-Arai J., Iwasaki H., Miyamoto T., Watanabe S., Akashi K. Enforced granulocyte/macrophage colony-stimulating factor signals do not support lymphopoiesis, but instruct lymphoid to myelomonocytic lineage conversion. J. Exp. Med. 197:2003;1311-1322.
64. Lian R.H., Kumar V. Murine natural killer cell progenitors and their requirements for development. Semin Immunol. 14:2002;453-460.
65. Rosmaraki E.E., Douagi I., Roth C., Colucci F., Cumano A., Di Santo J.P. Identification of committed NK cell progenitors in adult murine bone marrow. Eur. J. Immunol. 31:2001;1900-1909.
66. Ikawa T., Fujimoto S., Kawamoto H., Katsura Y., Yokota Y. Commitment to natural killer cells requires the helix-loop-helix inhibitor Id2. Proc. Natl. Acad. Sci. USA. 98:2001;5164-5169.
67. Christianson S.W., Greiner D.L., Deluca D., Leif J., Phillips N.E., Hayes S.M., Hayashi S., Joliat M.J., Lyons B.L., Shultz L.D. T cell developmental defects in 'viable motheaten' mice deficient in SHP-1 protein-tyrosine phosphatase. Developmental defects are corrected in vitro in the presence of normal hematopoietic-origin stromal cells and in vivo by exogenous IL-7. J. Autoimmun. 18:2002;119-130.
68. Qu C.K., Nguyen S., Chen J., Feng G.S. Requirement of Shp-2 tyrosine phosphatase in lymphoid and hematopoietic cell development. Blood. 97:2001;911-914.
69. Chen Y., Wen R., Yang S., Schuman J., Zhang E.E., Yi T., Feng G.S., Wang D. Identification of Shp-2 as a Stat5A phosphatase. J. Biol. Chem. 278:2003;16520-16527.
70. Simoncic P.D., Lee-Loy A., Barber D.L., Tremblay M.L., McGlade C.J. The T cell protein tyrosine phosphatase is a negative regulator of janus family kinases 1 and 3. Curr. Biol. 12:2002;446-453.
71. Alexander W.S. Suppressors of cytokine signalling (SOCS) in the immune system. Nat. Rev. Immunol. 2:2002;410-416 An excellent up-to-date overview of the feedback inhibitory loop in cytokine signaling.
72. Jegalian A.G., Wu H. Regulation of Socs gene expression by the proto-oncoprotein GFI-1B: two routes for STAT5 target gene induction by erythropoietin. J. Biol. Chem. 277:2002;2345-2352.
73. Matsumoto A., Seki Y., Kubo M., Ohtsuka S., Suzuki A., Hayashi I., Tsuji K., Nakahata T., Okabe M., Yamada S.et al. Suppression of STAT5 functions in liver, mammary glands, and T cells in cytokine-inducible SH2-containing protein 1 transgenic mice. Mol. Cell. Biol. 19:1999;6396-6407.
74. Marine J.C., McKay C., Wang D., Topham D.J., Parganas E., Nakajima H., Pendeville H., Yasukawa H., Sasaki A., Yoshimura A.et al. SOCS3 is essential in the regulation of fetal liver erythropoiesis. Cell. 98:1999;617-627.
75. + T lineage. This cell-type-specific function of SOCS1 illustrates a remarkable fine specificity of function of the negative regulators of cytokine signaling.
76. Ilangumaran S., Ramanathan S., La Rose J., Poussier P., Rottapel R. Suppressor of cytokine signaling 1 regulates IL-15 receptor signaling in CD8+CD44(high) memory T lymphocytes. J. Immunol. 171:2003;2435-2445.
77. -/- thymocytes exhibit diminished levels of SOCS1 protein.
78. Starr R., Willson T.A., Viney E.M., Murray L.J., Rayner J.R., Jenkins B.J., Gonda T.J., Alexander W.S., Metcalf D., Nicola N.A.et al. A family of cytokine-inducible inhibitors of signalling. Nature. 387:1997;917-921.
79. Metcalf D., Greenhalgh C.J., Viney E., Willson T.A., Starr R., Nicola N.A., Hilton D.J., Alexander W.S. Gigantism in mice lacking suppressor of cytokine signalling-2. Nature. 405:2000;1069-1073.
80. Croker B.A., Krebs D.L., Zhang J.G., Wormald S., Willson T.A., Stanley E.G., Robb L., Greenhalgh C.J., Forster I., Clausen B.E.et al. SOCS3 negatively regulates IL-6 signaling in vivo. Nat. Immunol. 4:2003;540-545.
81. Yasukawa H., Ohishi M., Mori H., Murakami M., Chinen T., Aki D., Hanada T., Takeda K., Akira S., Hoshijima M.et al. IL-6 induces an anti-inflammatory response in the absence of SOCS3 in macrophages. Nat. Immunol. 4:2003;551-556.
82. Matsumoto A., Seki Y., Watanabe R., Hayashi K., Johnston J.A., Harada Y., Abe R., Yoshimura A., Kubo M. A role of suppressor of cytokine signaling 3 (SOCS3/CIS3/SSI3) in CD28-mediated interleukin 2 production. J. Exp. Med. 197:2003;425-436.